{
     "PMID": "18461273",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20081105",
     "LR": "20171011",
     "IS": "0300-9564 (Print) 0300-9564 (Linking)",
     "VI": "115",
     "IP": "7",
     "DP": "2008 Jul",
     "TI": "MKC-231, a choline uptake enhancer: (3) Mode of action of MKC-231 in the enhancement of high-affinity choline uptake.",
     "PG": "1037-46",
     "LID": "10.1007/s00702-008-0049-0 [doi]",
     "AB": "MKC-231, a putative cholinergic activity, is reported to improve learning and memory impaired in AF64A-treated animals. MKC-231 enhances high-affinity choline uptake (HACU) known as the rate-limiting step of acetylcholine (ACh) synthesis. We investigated the mode of action (MOA) of HACU enhancement by MKC-231. Intracerebroventricular (i.c.v.) injections of AF64A (3 nmol/brain) resulted in significant HACU reduction in hippocampal synaptosomes. Treatment with MKC-231 increased Vmax of HACU and Bmax of [3H]-HC-3 binding 1.6 and 1.7-fold, respectively. In studies of [3H]-MKC-231 binding and Biacore analysis, MKC-231 showed noticeable affinity for cloned high-affinity choline transporters (CHT1). The present study suggests that MKC-231 directly affects trafficking of CHT1 and increases the numbers of transporter, working for HACU, at the synaptic membrane.",
     "FAU": [
          "Takashina, Ken",
          "Bessho, Tomoko",
          "Mori, Reiko",
          "Kawai, Kunji",
          "Eguchi, Junichi",
          "Saito, Ken-Ichi"
     ],
     "AU": [
          "Takashina K",
          "Bessho T",
          "Mori R",
          "Kawai K",
          "Eguchi J",
          "Saito K"
     ],
     "AD": "Pharmacology Department IV, Pharmacology Laboratory, Research Division, Mitsubishi Tanabe Pharma Corporation, 1000, Kamoshida-cho, Aoba-ku, Yokohama 227-0033, Japan. takashina.ken@mh.mt-pharma.co.jp",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article"
     ],
     "DEP": "20080507",
     "PL": "Austria",
     "TA": "J Neural Transm (Vienna)",
     "JT": "Journal of neural transmission (Vienna, Austria : 1996)",
     "JID": "9702341",
     "RN": [
          "0 (Aziridines)",
          "0 (MKC 231)",
          "0 (Membrane Transport Proteins)",
          "0 (Neurotransmitter Uptake Inhibitors)",
          "0 (Quinolines)",
          "0 (choline transporter)",
          "10028-17-8 (Tritium)",
          "312-45-8 (Hemicholinium 3)",
          "A668M9E227 (ethylcholine aziridinium)",
          "N91BDP6H0X (Choline)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Aziridines/pharmacology",
          "COS Cells",
          "Cell Membrane/drug effects/metabolism",
          "Cercopithecus aethiops",
          "Choline/analogs & derivatives/*metabolism/pharmacology",
          "Drug Interactions",
          "Hemicholinium 3/pharmacology",
          "Hippocampus/drug effects/ultrastructure",
          "Male",
          "Membrane Transport Proteins/genetics/metabolism",
          "Neurotransmitter Uptake Inhibitors/pharmacology",
          "Protein Binding/drug effects",
          "Quinolines/*pharmacology",
          "Radioligand Assay",
          "Rats",
          "Rats, Wistar",
          "Synaptosomes/*drug effects/*metabolism",
          "Transfection",
          "Tritium/metabolism"
     ],
     "EDAT": "2008/05/08 09:00",
     "MHDA": "2008/11/06 09:00",
     "CRDT": [
          "2008/05/08 09:00"
     ],
     "PHST": [
          "2007/08/03 00:00 [received]",
          "2008/03/28 00:00 [accepted]",
          "2008/05/08 09:00 [pubmed]",
          "2008/11/06 09:00 [medline]",
          "2008/05/08 09:00 [entrez]"
     ],
     "AID": [
          "10.1007/s00702-008-0049-0 [doi]"
     ],
     "PST": "ppublish",
     "SO": "J Neural Transm (Vienna). 2008 Jul;115(7):1037-46. doi: 10.1007/s00702-008-0049-0. Epub 2008 May 7.",
     "term": "hippocampus"
}